病理完整反应的预测因素及其在早期乳腺癌的预后价值:现实世界队列研究
Selami Bayram1, Ali Murat Tatli1, Muharrem Okan Cakir2
1Department of Medical Oncology, Memorial Antalya Hospital, 07025 Antalya, Türkiye.
Current oncology (Toronto, Ont.)
|November 26, 2025
概括
在早期乳腺癌 (EBC) 中,在新辅助全身疗法 (NAST) 后实现病理完整反应 (pCR) 与更好的无病生存率 (DFS) 有关. 预测因素包括HER2阳性,高Ki-67,低ER表达和放射性反应.
科学领域:
- 在瘤学瘤学.
- 乳腺癌研究研究 乳腺癌研究
- 临床试验分析
背景情况:
- 在新辅助全身疗法 (NAST) 后的病理完整反应 (pCR) 是早期乳腺癌 (EBC) 的关键预后指标,特别是在三阴性 (TNBC) 和HER2阳性亚型中.
- 有限的现实世界数据存在于PCR的预测因素及其对患者生存结果的后续影响.
研究的目的:
- 确定与NAST治疗的II-III期EBC患者中实现pCR的独立预测因子.
- 评估pCR与长期生存结果之间的关联,特别是无病生存率 (DFS) 和整体生存率 (OS).
主要方法:
- 在2015年至2023年期间,对200名II-III期EBC患者进行了以NAST治疗的回顾性分析.
- 临床病理学和治疗变量被评估与pCR的关联 (ypT0/is ypN0).
- 用米勒-佩恩评分系统评估组织学回归;采用多变量后勤回归和卡普兰-梅尔方法.
主要成果:
- 总体PCR率为36.0%,在HER2阳性 (65%) 和TNBC (56%) 亚型中比率更高.
- 独立的pCR预测因素包括HER2阳性,高Ki-67 (>47.5%),低ER表达 (<10%),和放射性完整反应.
- 实现pCR的患者显示5年DFS显著改善 (91.5%对72.8%),但没有统计学上显著的OS (92.2%对87.0%).
结论:
- HER2阳性,高Ki-67,低ER表达和放射性完整反应是PCR的关键独立预测因素.
- 获得pCR与改善的DFS有很强的相关性,加强其作为TNBC和HER2阳性EBC的替代终点的作用.
- 这些发现表明,对于无法实现pCR的患者,需要采取治疗升级策略,以改善整体存活率.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
631
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
475
相关概念视频
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
387
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
387
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
